Archive · 1 Jul 2025
Welcure Drugs Stock Soars After Securing Export Orders
Imagine a small company called Welcure that makes medicines.
They just got a big order to sell their products to other countries!
This good news made the company's stock price go up a lot in one day.
They made about ₹85.6 crore from these new orders.
In the past, the company didn't make as much money, but recently, things have been going better, and they made a profit.
Welcure has been around since 1992 and is based in New Delhi.
Welcure Drugs and Pharmaceuticals shares hit a 5% upper circuit.
The surge followed the announcement of two export sourcing orders.
These orders, worth approximately ₹85.6 crore, are with Giant Exim and Ravina International.
The company reported a standalone net profit of ₹2.54 crore for the quarter ending March 2025.
Welcure specializes in producing and marketing various pharmaceutical products.
- Who
- Welcure Drugs and Pharmaceuticals.
- What
- Welcure Drugs and Pharmaceuticals share price surged following export orders.
- When
- The stock surged in Tuesday's trading session.
- Where
- The company is based in New Delhi.
- Why
- Due to securing export orders worth ₹85.6 crore.
- Company
- Welcure Drugs and Pharmaceuticals
- Stock Movement
- Hit 5% upper circuit
- Share Price
- ₹14.28 (at upper circuit)
- Export Order Value
- ₹85.6 crore
- Q4 2025 Net Profit
- ₹2.54 crore
- Established
- 1992